Abstract
IL-17-producing CD4+ T helper (Th17) cells are important for immunity against extracellular pathogens and in autoimmune diseases. The factors that drive Th17 development in human remain a matter of debate. Here we show that, compared with classic CD28 costimulation, alternative costimulation via the CD5 or CD6 lymphocyte receptors forms a superior pathway for human Th17-priming. In the presence of the Th17- promoting cytokines IL-1β, IL-6, IL-23, and transforming growth factor-β (TGF-β), CD5 costimulation induces more Th17 cells that produce higher amounts of IL-17, which is preceded by prolonged activation of signal transducer and activator of transcription 3 (STAT3), a key regulator in Th17 differentiation, and enhanced levels of the IL-17-associated transcription factor retinoidrelated orphan receptor-γt (ROR-γt). Strikingly, these Th17-promoting signals critically depend on CD5-induced elevation of IL-23 receptor (IL-23R) expression. The present data favor the novel concept that alternative costimulation via CD5, rather than classic costimulation via CD28, primes naive T cells for stable Th17 development through promoting the expression of IL-23R. © 2011 by The American Society of Hematology.
Cite
CITATION STYLE
De Wit, J., Souwer, Y., Van Beelen, A. J., De Groot, R., Muller, F. J. M., Bos, H. K., … Van Ham, S. M. (2011). CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation. Blood, 118(23), 6107–6114. https://doi.org/10.1182/blood-2011-05-352682
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.